FT Health Features Global Health-Related Original Interviews, News Roundups

FT Health: Cities lead the way on public health
The latest issue of the Financial Times’ weekly global health newsletter discusses how public health initiatives and urban planning can enhance health promotion within the world’s cities. The newsletter also features a roundup of other global health-related news stories (Dodd, 8/25).

FT Health: Tough times for generics
The August 18 issue discusses access to and regulatory issues surrounding generic drugs in the U.S. and worldwide. The newsletter also features a roundup of other global health-related news stories (Dodd, 8/18).

FT Health: The pursuit of the impossible
The August 11 issue discusses ethical issues surrounding some medical decisions, including the case of Charlie Gard. The newsletter also features an interview with Detlev Ganten, president of the World Health Summit (October 15-17) and former chief executive and chair of the Charité university hospital in Berlin, as well as a global health news roundup (Dodd/Jack, 8/11).

FT Health: The security challenge
The August 4 issue discusses health and biomedical cybersecurity and the challenges of keeping medical data safe. The newsletter also features an interview with Paul Stoffels, chief scientific officer at Johnson & Johnson, about the company’s research into TB and HIV treatments and vaccines, as well as a news roundup (Dodd/Jack, 8/4).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.